123 related articles for article (PubMed ID: 7974686)
1. Lack of effect of ivermectin on prepatent guinea-worm: a single-blind, placebo-controlled trial.
Issaka-Tinorgah A; Magnussen P; Bloch P; Yakubu A
Trans R Soc Trop Med Hyg; 1994; 88(3):346-8. PubMed ID: 7974686
[TBL] [Abstract][Full Text] [Related]
2. Failure of thiabendazole and metronidazole in the treatment and suppression of guinea worm disease.
Belcher DW; Wunapa FK; Ward WB
Am J Trop Med Hyg; 1975 May; 24(3):444-6. PubMed ID: 125551
[TBL] [Abstract][Full Text] [Related]
3. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
[TBL] [Abstract][Full Text] [Related]
4. Letter: Guinea-worms and metronidazole.
Kulkarni DR; Nagalotimath SJ
Trans R Soc Trop Med Hyg; 1975; 69(1):169-70. PubMed ID: 124967
[No Abstract] [Full Text] [Related]
5. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
[TBL] [Abstract][Full Text] [Related]
6. Chemoprophylactic drug trials for treatment of dracunculiasis using the Dracunculus insignis-ferret model.
Eberhard ML; Brandt FH; Ruiz-Tiben E; Hightower A
J Helminthol; 1990 Jun; 64(2):79-86. PubMed ID: 2143770
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
[TBL] [Abstract][Full Text] [Related]
8. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
Awadzi K; Dadzie KY; Kläger S; Gilles HM
Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
[TBL] [Abstract][Full Text] [Related]
10. Fall in incidence of guinea-worm infection in western Nigeria after periodic treatment of infected persons.
Kale OO
Bull World Health Organ; 1982; 60(6):951-7. PubMed ID: 6218928
[TBL] [Abstract][Full Text] [Related]
11. The possible mode of action of some chemotherapeutic agents in guinea worm disease.
Muller R
Trans R Soc Trop Med Hyg; 1971; 65(6):843-4. PubMed ID: 4258078
[No Abstract] [Full Text] [Related]
12. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
Diallo S; Aziz MA; Lariviere M; Diallo JS; Diop-Mar I; N'Dir O; Badiane S; Py D; Schulz-Key H; Gaxotte P
Trans R Soc Trop Med Hyg; 1986; 80(6):927-34. PubMed ID: 3299905
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
Ottesen EA; Vijayasekaran V; Kumaraswami V; Perumal Pillai SV; Sadanandam A; Frederick S; Prabhakar R; Tripathy SP
N Engl J Med; 1990 Apr; 322(16):1113-7. PubMed ID: 2181312
[TBL] [Abstract][Full Text] [Related]
14. Ivermectin does not reduce the burden of itching in an onchocerciasis endemic community.
Whitworth JA; Luty AJ; Maude GH; Morgan D; Downham MD; Taylor DW
Trans R Soc Trop Med Hyg; 1992; 86(3):281-3. PubMed ID: 1412653
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.
Awadzi K; Opoku NO; Addy ET; Quartey BT
Trop Med Parasitol; 1995 Jun; 46(2):131-7. PubMed ID: 8525285
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
[TBL] [Abstract][Full Text] [Related]
17. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin-induced immunopotentiation in onchocerciasis: recognition of selected antigens following a single dose of ivermectin.
Akuffo H; Maasho K; Lavebratt C; Engström K; Britton S
Clin Exp Immunol; 1996 Feb; 103(2):244-52. PubMed ID: 8565307
[TBL] [Abstract][Full Text] [Related]
19. Effect of two single doses of ivermectin in treatment of asymptomatic bancroftian filariasis in two villages in the Nile Delta, Egypt.
Youssef FG; Hassanein SH; Abdel-Fatah MS; el-Sharkawy IM
J Egypt Soc Parasitol; 1997 Apr; 27(1):83-92. PubMed ID: 9097530
[TBL] [Abstract][Full Text] [Related]
20. Development of reactive onchocercal skin lesions during a placebo-controlled trial with ivermectin among persons without lesions at baseline.
Brieger WR; Kale OO; Ososanya OO
Trop Doct; 2001 Apr; 31(2):96-8. PubMed ID: 11321284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
